US HB3012 | 2015-2016 | 114th Congress
Status
Spectrum: Moderate Partisan Bill (Republican 53-9)
Status: Introduced on July 9 2015 - 25% progression, died in committee
Action: 2015-07-29 - Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.
Pending: House Subcommittee on Crime, Terrorism, Homeland Security, And Investigations Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on July 9 2015 - 25% progression, died in committee
Action: 2015-07-29 - Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.
Pending: House Subcommittee on Crime, Terrorism, Homeland Security, And Investigations Committee
Text: Latest bill text (Introduced) [PDF]
Summary
Right to Try Act of 2015 Bars the federal government from prohibiting or restricting the production, manufacture, distribution, prescribing, dispensing, possession, or use of an experimental drug, biological product, or device that is: (1) intended to treat a patient who has been diagnosed with a terminal illness; and (2) authorized by, and in accordance with, state law. Defines an "experimental drug, biological product, or device" as one that: (1) has successfully completed a phase 1 clinical investigation; (2) remains under investigation in a clinical trial approved by the Food and Drug Administration; and (3) is not approved, licensed, or cleared for commercial distribution under the Federal Food, Drug, or Cosmetic Act or the Public Health Service Act.
Title
Right to Try Act of 2015
Sponsors
History
| Date | Chamber | Action |
|---|---|---|
| 2015-07-29 | House | Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations. |
| 2015-07-10 | House | Referred to the Subcommittee on Health. |
| 2015-07-09 | House | Referred to House Judiciary |
| 2015-07-09 | House | Referred to House Energy and Commerce |
| 2015-07-09 | House | Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. |
| 2015-07-09 | House | Introduced in House |
Same As/Similar To
SB2912 (Related) 2016-09-22 - Committee on Homeland Security and Governmental Affairs. Hearings held.
Subjects
Drug safety, medical device, and laboratory regulation
Drug therapy
Health
Long-term, rehabilitative, and terminal care
Prescription drugs
Drug therapy
Health
Long-term, rehabilitative, and terminal care
Prescription drugs
US Congress State Sources
| Type | Source |
|---|---|
| Summary | https://www.congress.gov/bill/114th-congress/house-bill/3012/all-info |
| Text | https://www.congress.gov/114/bills/hr3012/BILLS-114hr3012ih.pdf |
